AIBOTICS, INC.
For the period ended Sep 30, 2025. Filed Nov 19, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 19, 2025
AIBTStored price and day change unavailable
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-06-30; filed 2025-08-19.
0001096906-25-001375
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2025-09-30; filed 2025-11-19.
0001096906-25-001895
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 52 previous paragraphs and 54 current paragraphs.
33 unchanged; 12 reworded; 7 added; 7 removed; 0 previous and 2 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (7)
Current report
Operating expenses for the three months ended September 30, 2025 and 2024 consisted solely of general and administrative expenses. For the three months ended September 30, 2025, general and administrative expenses increased by $95,108, or 25%, compared to the same period in 2024, from $385,257 to $480,365. The increase was primarily attributed to $119,372 in consulting fees, $15,000 in board compensation fees, $16,878 in advertising and marketing expenses offset by a decrease of $70,700 in product development expense.
Current report
Loss on extinguishment of liabilities for the three months ended September 30, 2025 increased by $38,403 or 100%, compared to the same period in 2024, increasing from $0 to $38,403. The increase was primarily driven by the loss recognized on the conversion of accrued interest during the current period, whereas no such transactions occurred in the prior-year period.
Current report
Nine Months Ended September 30, 2025 as Compared to the Nine Months Ended September 30, 2024
Current report
Operating expenses for the nine months ended September 30, 2025 and 2024 consisted solely of general and administrative expenses. For the nine months ended September 30, 2025, general and administrative expenses increased by $235,052, or 21%, compared to the same period in 2024, from $1,137,539 to $1,372,591. The increase was primarily attributed to $161,332 in consulting fees, $45,000 in board compensation fees, $23,129 in advertising and marketing expenses offset by a decrease of $9,113 in product development expense.
Current report
Interest expense for the nine months ended September 30, 2025 decreased by $52,875 or 24%, compared to the same period in 2024, decreasing from $219,222 to $166,347 The decrease was primarily driven by the absence of interest expense related to convertible notes following the conversion of accrued interest and overall lower interest-bearing balances during the period.
Current report
Loss on extinguishment of liabilities for the three months ended September 30, 2025 increased by $70,713 or 100%, compared to the same period in 2024, increasing from $0 to $70,713. The increase was primarily driven by the loss recognized on the conversion of accrued interest during the current period, whereas no such transactions occurred in the prior-year period.
Current report
Financing activities provided by cash flows of $417,009 and $165,000 for the nine months ended September 30, 2025 and 2024, respectively. For the nine months ended September 30, 2025, cash provided by financing activities was primarily driven by proceeds from convertible notes payable of $250,000 and proceeds from the issuance of common stock of $167,009. For the nine months ended September 30, 2024, cash provided by financing activities was primarily driven by proceeds from notes payable – related party of $165,000.
Removed paragraphs (7)
Previous report
Operating expenses for the three months ended June 30, 2025 and 2024 consisted solely of general and administrative expenses. For the three months ended June 30, 2025, general and administrative expenses primarily included amortization expenses of approximately $164,000, board compensation of $40,000, consulting fees of approximately $105,000, and legal and professional services of approximately $37,000.
Previous report
For the three months ended June 30, 2025, general and administrative expenses decreased by $30,831, or 8%, compared to the same period in 2024, decreasing from $391,410 to $360,579. The decrease was primarily attributable to a reduction in product development expenses of approximately $58,000, partially offset by an increase in consulting fees of approximately $24,000.
Previous report
Six Months Ended June 30, 2025 as Compared to the Six Months Ended June 30, 2024
Previous report
Operating expenses for the six months ended June 30, 2025 and 2024 consisted solely of general and administrative expenses. For the six months ended June 30, 2025, general and administrative expenses primarily included amortization expenses of approximately $328,000, board compensation of $80,000, consulting fees of approximately $204,000, product development expense of approximately $169,000 and legal and professional services of approximately $80,000.
Previous report
For the six months ended June 30, 2025, general and administrative expenses increased by $139,944, or 19%, compared to the same period in 2024, increasing from $752,282 to $892,226. The increase was primarily attributable to an increase in board compensation fees of approximately $30,000, increase in consulting fees of approximately $42,000, and increase in product development expenses of approximately $62,000.
Previous report
Interest expense for the six months ended June 30, 2025 increased by $43,168, or 30%, compared to the same period in 2024, increasing from $144,335 to $187,503. The increase was primarily attributable to the gain on conversion of accrued interest offset by the absence of interest expense related to debt discount amortization on the Company’s convertible notes during the six months ended June 30, 2025.
Previous report
Financing activities produced cash flows of $250,000 and $165,000 for the six months ended June 30, 2025, and 2024, respectively.
Reworded paragraphs (12)
Previous wording
Other expense for the three months ended June 30, 2025 and 2024 was composed of interest expense.
Current wording
Other expense for the three months ended September 30, 2025 and 2024 were composed of interest expense and loss on extinguishment of liabilities.
Previous wording
Interest expense for the three months ended June 30, 2025, increased by $46,305, or 58%, compared to the same period in 2024, decreasing from $79,265 to $125,570. The increase was primarily due to the gain on conversion of accrued interest offset by the absence of interest expense related to debt discount amortization on the Company’s convertible notes during the three months ended June 30, 2025.
Current wording
Interest expense for the three months ended September 30, 2025 decreased by $63,733 or 85%, compared to the same period in 2024, decreasing from $74,887 to $11,154 The decrease was primarily driven by the absence of interest expense related to convertible notes following the conversion of accrued interest and overall lower interest-bearing balances during the period.
Previous wording
For the three months ended June 30, 2025 and 2024 we had a net loss of $486,149 and $470,675, respectively.
Current wording
For the three months ended September 30, 2025 and 2024 we had a net loss of $529,921 and $460,144, respectively.
Previous wording
We did have revenue and cost of revenue from operations for the six months ended June 30, 2025, of $2,183, as compared to $0 revenue and cost of revenue from operations for the six months ended June 30, 2024.
Current wording
We had revenue and cost of revenue from operations for the nine months ended September 30, 2025, of $2,183, as compared to $0 revenue and cost of revenue from operations for the nine months ended September 30, 2024.
Previous wording
Other expense for the six months ended June 30, 2025 and 2024 was composed of interest expense.
Current wording
Other expense for the nine months ended September 30, 2025 and 2024 were composed of interest expense and loss on extinguishment of liabilities.
Previous wording
For the six months ended June 30, 2025 and 2024, we had a net loss of $1,077,546 and $896,617, respectively.
Current wording
For the nine months ended September 30, 2025 and 2024, we had a net loss of $1,607,467 and $1,356,761, respectively.
Previous wording
Liquidity refers to a company’s ability to generate sufficient cash to meet its short-term financial obligations. As of June 30, 2025, we had $242,179 in cash and cash equivalents, compared to $185,097 as of December 31, 2024, representing an increase of $57,082. This increase was primarily driven by cash used in operations. As of June 30, 2025, we had undiscounted obligations of approximately $1.3 million related to indebtedness due within one year.
Current wording
Liquidity refers to a company’s ability to generate sufficient cash to meet its short-term financial obligations. As of September 30, 2025, we had $230,470 in cash and cash equivalents, compared to $185,097 as of December 31, 2024, representing an increase of $45,373. This increase was primarily driven by cash provided by financing activities. As of September 30, 2025, we had undiscounted obligations of approximately $1.3 million related to indebtedness due within one year.
Previous wording
As of June 30, 2025, we had a working capital deficiency of $5,149,741 as of June 30, 2025, compared to a deficiency of $4,666,666 as of December 31, 2024. Our current assets totaled $242,179, consisting almost entirely of cash. Current liabilities totaled $5,391,920, primarily comprised of related party accrued expenses, convertible notes payable, and shares to be issued. As of June 30, 2025, we had an accumulated deficit of $11,831,802, up from $10,809,256 as of December 31, 2024, reflecting continued operating losses.
Current wording
As of September 30, 2025, we had a working capital deficit of $4,661,176, compared to a working capital deficit of $4,666,666 as of December 31, 2024. Our current assets totaled $241,396, consisting primarily of cash. Current liabilities totaled $4,902,572, which were mainly comprised of related party accrued expenses, convertible notes payable, and shares to be issued.
Previous wording
Our monthly operating costs averaged approximately $10,000 per month for the six months ended June 30, 2025, excluding capital expenditure. We did not have capital expenditures during the six months ended June 30, 2025. We plan to fund our operations with our cash on hand and additional financing.
Current wording
Our monthly operating costs averaged approximately $10,000 per month for the nine months ended September 30, 2025, excluding capital expenditure. We did not have capital expenditures during the nine months ended September 30, 2025. We plan to fund our operations with our cash on hand and additional financing.
Previous wording
Operating activities used net cash of $192,918 for the six months ended June 30, 2025, as compared to using net cash of $164,229 for the six months ended June 30, 2024. For the six months ended June 30, 2025, cash used in operating activities was primarily driven by our net loss of $1,077,546; offset primarily by amortization expense of approximately $328,000, the gain recognized on common stock issued to settle liability of approximately $55,000, the increase in related party accrued expenses of approximately $94,000, the increase in accrued interest of approximately $60,038, and the increase in accounts payable and accrued expenses of approximately $344,739. For the six months ended June 30, 2024, cash used in operating activities was primarily driven by our net loss of $896,617; offset primarily by the amortization of debt discounts of approximately $332,000, and the increase in related party and non-related party accrued interest of approximately $279,000, and the increase in accounts payable and accrued expenses of approximately $112,000.
Current wording
Operating activities used net cash of $371,636 for the nine months ended September 30, 2025, as compared to using net cash of $241,776 for the nine months ended September 30, 2024. For the nine months ended September 30, 2025, cash used in operating activities was primarily driven by our net loss of $1,607,467; offset primarily by amortization expense of approximately $496,000, the gain recognized on common stock issued to settle liability of approximately $70,712, the increase in accrued interest of approximately $52,798, the increase in accounts payable and accrued expenses of approximately $484,935 and increase in accrued expenses-related of $126,000. For the nine months ended September 30, 2024, cash used in operating activities was primarily driven by our net loss of $1,356,761;
Previous wording
Investing activities used net cash of $0 for the six months ended June 30, 2025, and 2024.
Current wording
Investing activities used net cash of $0 for the nine months ended September 30, 2025, and 2024.
Previous wording
For the six months ended June 30, 2025, the Company incurred a net loss of $1,077,546, had negative cash flows from operations of $192,918 and may incur additional future losses. At June 30, 2025, the Company had total current assets of $242,179 and total current liabilities of $5,393,920, resulting in a working capital deficit of $5,151,741. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.
Current wording
For the nine months ended September 30, 2025, the Company incurred a net loss of $1,607,467, had negative cash flows from operations of $371,636 and may incur additional future losses. At September 30, 2025, the Company had total current assets of $241,396 and total current liabilities of $4,902,572, resulting in a working capital deficit of $4,661,176. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.
Rearranged current paragraphs (2)
Current report — wording carried from elsewhere
As of September 30, 2025, we had an accumulated deficit of $12,416,723, compared to $10,809,256 as of December 31, 2024, reflecting continued operating losses during the period.
Current report — wording carried from elsewhere
offset primarily by the amortization expense of approximately $500,000, and the increase in related party and non-related party accrued interest of approximately $426,000, and the increase in accounts payable and accrued expenses of approximately $180,000.